Patents by Inventor Daniel DiSepio

Daniel DiSepio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenyl-piperazine derivatives as modulators of muscarinic receptors
    Publication number: 20090239873
    Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
    Type: Application
    Filed: December 31, 2008
    Publication date: September 24, 2009
    Inventors: Miguel Garcia-Guzman Blanco, Daniele Bergeron, Peter D. J. Grootenhuis, Dennis Hurley, Akiko Nakatani, Lewis R. Makings, Daniel DiSepio, Gabriel Raffai
  • Phenyl-piperazine derivatives as modulators of muscarinic receptors
    Patent number: 7563795
    Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: July 21, 2009
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Miguel Garcia-Guzman Blanco, Daniele Bergeron, Peter D. J. Grootenhuis, Dennis Hurley, Akiko Nakatani, Lewis R. Makings, Daniel DiSepio, Gabriel Raffai
  • Phenyl-piperazine derivatives as modulators of muscarinic receptors
    Publication number: 20050137211
    Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.
    Type: Application
    Filed: September 27, 2004
    Publication date: June 23, 2005
    Inventors: Miguel Blanco, Daniele Bergeron, Peter Grootenhuis, Dennis Hurley, Akiko Nakatani, Lewis Makings, Daniel DiSepio, Gabriel Raffai
  • Retinoid induced gene
    Patent number: 6294657
    Abstract: A novel human cDNA, called TIG3 (Tazarotene Induced Gene 3), inducible by RAR-selective retinoids and structurally related to a known tumor suppressor gene. Methods of detecting the TIG3 polynucleotide.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: September 25, 2001
    Assignee: Allergan Sales, Inc.
    Inventors: Sunil Nagpal, Daniel DiSepio, Roshantha A. Chandraratna
  • Retinoid induced gene
    Patent number: 5776687
    Abstract: A novel human cDNA, called TIG3 (Tazarotene Induced Gene 3), inducible by RAR-selective retinoids and structurally related to a known tumor suppressor gene. Methods of detecting the TIG3 polynucleotide.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: July 7, 1998
    Assignee: Allergan
    Inventors: Sunil Nagpal, Daniel DiSepio, Roshantha A. Chandraratna